Its U.S.-listed and Canadian shares ended down about 21 per cent as the company withdrew its forecast of becoming EBITDA positive by the end of fiscal 2022 due to the coronavirus crisis.

There's a growing movement of people championing the benefits of psychedelics, and they're following the path that led to cannabis legalization.

Shares of Canopy Growth Corp. got a lift after the cannabis producer named Klein — chief financial officer at Constellation Brands, Canopy's largest shareholder — as its new CEO.

Constellation Brands, Canopy's biggest shareholder, said last week that it was "not pleased" with Canopy's recent year-end results.

Canopy Growth's Q3 revenue - from the first quarter of legalization - soared, but so did its loss from operations.

The Smiths Falls, Ont.-based company says more than 95 per cent of the votes at its annual meeting supported the private placement of 104.5 million shares and 139.7 million warrants to Constellation subsidiary CBG Holdings LLC.

Chief executive Bruce Linton says he has lined up an option to acquire a "humongous" greenhouse in California as part of a broader strategy to enter the U.S. market quickly, even though the drug is currently illegal at the federal level.

Cannabis shares have been among the best performers on Canada's stock market. Is it too late to join the party?

Come July, 2018, Canadians will need a lot of legal pot. Where will it come from? Licenced producers say they can meet the demand; their smaller rivals doubt it.

Fears of a U.S. federal marijuana crackdown are dimming prospects for an American cannabis industry, a Canadian producer says.